Merge branch '20190515' into 'master'

Blocking Rules Update 20190515

Closes #641

See merge request !358

sites/derstandard.at/index.md

@@ -50,16 +50,3 @@ Some explanation of the block rule.
   - type: block
 ```
 -->
-
-## Avoid blocker blocker on derstandard.at
-
-([Issue #718](https://source.ind.ie/better/content/issues/718))
-
-```mson
-- trigger:
-  - if-domain: derstandard.at
-  - url-filter: at.staticfiles.at/js/purwall
-  - load-type: third-party
-- action:
-  - type: block
-```

trackers/1rx.io/index.md

@@ -33,7 +33,7 @@
 ## Prevalence
 
 <!-- prevalence -->
-**High:** found on 2.5% of surveyed sites (179 instances observed).
+**High:** found on 2.5% of surveyed sites (180 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/2mdn.net/index.md

@@ -33,7 +33,7 @@
 ## Prevalence
 
 <!-- prevalence -->
-**High:** found on 4.9% of surveyed sites (359 instances observed).
+**High:** found on 4.9% of surveyed sites (360 instances observed).
 <!-- /prevalence -->
 
 

trackers/3lift.com/index.md

@@ -38,7 +38,7 @@
 ## Prevalence
 
 <!-- prevalence -->
-**High:** found on 1.7% of surveyed sites (122 instances observed).
+**High:** found on 1.7% of surveyed sites (123 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/adnxs.com/index.md

@@ -34,7 +34,7 @@ adnxs.com
 ## Prevalence
 
 <!-- prevalence -->
-**Pandemic:** found on 16.8% of surveyed sites (1224 instances observed).
+**Pandemic:** found on 16.8% of surveyed sites (1226 instances observed).
 <!-- /prevalence -->
 
 

trackers/adsrvr.org/index.md

@@ -34,7 +34,7 @@ adsrvr.org
 ## Prevalence
 
 <!-- prevalence -->
-**Pandemic:** found on 10.9% of surveyed sites (793 instances observed).
+**Pandemic:** found on 10.9% of surveyed sites (794 instances observed).
 <!-- /prevalence -->
 
 

trackers/advertising.com/index.md

@@ -34,7 +34,7 @@ advertising.com
 ## Prevalence
 
 <!-- prevalence -->
-**Epidemic:** found on 6.4% of surveyed sites (465 instances observed).
+**Epidemic:** found on 6.4% of surveyed sites (467 instances observed).
 <!-- /prevalence -->
 
 

trackers/agkn.com/index.md

@@ -45,7 +45,7 @@ agkn.com
 ## Prevalence
 
 <!-- prevalence -->
-**High:** found on 4.3% of surveyed sites (311 instances observed).
+**High:** found on 4.3% of surveyed sites (313 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/akamai.net/index.md

@@ -41,7 +41,7 @@ Although the content itself is allowed to load, we block cookies to make sure th
 ## Prevalence
 
 <!-- prevalence -->
-**Moderate:** found on 0.9% of surveyed sites (63 instances observed).
+**Moderate:** found on 0.9% of surveyed sites (64 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/akamaized.net/index.md

@@ -48,7 +48,7 @@ Although the content itself is allowed to load, we block cookies to make sure th
 ## Prevalence
 
 <!-- prevalence -->
-**Moderate:** found on 0.9% of surveyed sites (65 instances observed).
+**Moderate:** found on 0.9% of surveyed sites (66 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/atwola.com/index.md

@@ -31,7 +31,7 @@ atwola.com
 ## Prevalence
 
 <!-- prevalence -->
-**Moderate:** found on 0.4% of surveyed sites (26 instances observed).
+**Moderate:** found on 0.2% of surveyed sites (12 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/bannerflow.com/index.md

@@ -33,7 +33,7 @@ bannerflow.com
 ## Prevalence
 
 <!-- prevalence -->
-**High:** found on 1.0% of surveyed sites (73 instances observed).
+**Moderate:** found on 0.5% of surveyed sites (35 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/betrad.com/index.md

@@ -34,7 +34,7 @@ betrad.com
 ## Prevalence
 
 <!-- prevalence -->
-**High:** found on 2.6% of surveyed sites (192 instances observed).
+**High:** found on 2.7% of surveyed sites (194 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/bidswitch.net/index.md

@@ -33,7 +33,7 @@ bidswitch.net
 ## Prevalence
 
 <!-- prevalence -->
-**Epidemic:** found on 9.4% of surveyed sites (686 instances observed).
+**Epidemic:** found on 9.4% of surveyed sites (687 instances observed).
 <!-- /prevalence -->
 
 

trackers/bluekai.com/index.md

@@ -34,7 +34,7 @@ bluekai.com
 ## Prevalence
 
 <!-- prevalence -->
-**Epidemic:** found on 5.8% of surveyed sites (421 instances observed).
+**Epidemic:** found on 5.8% of surveyed sites (422 instances observed).
 <!-- /prevalence -->
 
 

trackers/casalemedia.com/index.md

@@ -33,7 +33,7 @@ casalemedia.com
 ## Prevalence
 
 <!-- prevalence -->
-**Epidemic:** found on 8.6% of surveyed sites (623 instances observed).
+**Epidemic:** found on 8.6% of surveyed sites (624 instances observed).
 <!-- /prevalence -->
 
 

trackers/cloudflare.com/index.md

@@ -36,7 +36,7 @@ Although the content itself is allowed to load, we block cookies to make sure th
 ## Prevalence
 
 <!-- prevalence -->
-**Epidemic:** found on 10.0% of surveyed sites (726 instances observed).
+**Epidemic:** found on 10.0% of surveyed sites (727 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/contextweb.com/index.md

@@ -43,7 +43,7 @@ contextweb.com
 ## Prevalence
 
 <!-- prevalence -->
-**High:** found on 3.2% of surveyed sites (231 instances observed).
+**High:** found on 3.2% of surveyed sites (232 instances observed).
 <!-- /prevalence -->
 
 ## Notes

trackers/criteo.com/index.md

@@ -34,7 +34,7 @@ criteo.com
 ## Prevalence
 
 <!-- prevalence -->
-**Pandemic:** found on 13.4% of surveyed sites (978 instances observed).
+**Pandemic:** found on 13.4% of surveyed sites (979 instances observed).
 <!-- /prevalence -->
 
 

trackers/criteo.net/index.md

@@ -30,7 +30,7 @@ criteo.net
 ## Prevalence
 
 <!-- prevalence -->
-**Epidemic:** found on 8.5% of surveyed sites (619 instances observed).
+**Epidemic:** found on 8.5% of surveyed sites (620 instances observed).
 <!-- /prevalence -->